Benefits of angiography questioned by US study
This article was originally published in Clinica
Angiography provides no significant benefit to patients in terms of survival or health-related quality of life, concludes a study sponsored by the US Agency for Health Care Policy and Research. The results of an analysis of Medicare patients in New York and Texas, published in the New England Medical Journal (August 31st), show that the higher use of coronary angiography in Texas than in New York did not significantly affect outcomes.
You may also be interested in...
Aetion is also working with the US Food and Drug Administration and a number of biopharma companies on projects involving use of real-world evidence.
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.
The biopharma sector is often accused of a being a slow-moving engine, but a look back over the last 20 years reveals that a lot has changed. In Vivo explores the history of high-impact M&A transactions in the industry between 1999 and 2019.